Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension

Overview

Study of the efficacy and tolerance of Motens® (lacidipine) in patients with essential hypertension. To obtain information on the dosage used in practice and the tolerance at the start of treatment (12 weeks)

Full Title of Study: “Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension, Under Normal Conditions Compared With an Open Clinical Trial”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 1999

Interventions

  • Drug: Motens® (lacidipine)

Arms, Groups and Cohorts

  • Motens

Clinical Trial Outcome Measures

Primary Measures

  • Assessment of efficacy by the investigator on a 4-point verbal rating scale based on changes in blood pressure
    • Time Frame: Up to 12 weeks after start of drug administration
  • Assessment of tolerability by investigator on a 4-point verbal rating scale
    • Time Frame: Up to 12 weeks after start of drug administration
  • Number of patients with adverse events
    • Time Frame: Up to 12 weeks after start of drug administration

Participating in This Clinical Trial

Inclusion Criteria

Non-hospitalised patients of both sexes aged 18 years or more with essential hypertension requiring treatment according to the recommendations of the German League for Hypertension

Exclusion Criteria

Patients who had the contraindications listed in the product information (the case report file contained a copy of the product information)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Boehringer Ingelheim
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.